—

GENERAL ATLANTIC, L.P.

Q4 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    13

  • Value ($000)

    $2,872,723

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001017645
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

DLOCAL

CL A
G29018101
$659.73M
23 %

46,656,695

---

CHIME

COM SHS CL A
16935C109
$535.11M
19 %

21,259,683

---

XP, INC

CL A
G98239109
$371.58M
13 %

22,699,133

A
ALKT

ALKAMI

COM
01644J108
$276.64M
10 %

11,991,480

A
ALHC

ALIGNMENT HEALTHCARE

COM
01625V104
$260.06M
9 %

13,167,733

R
RVMD

REVOLUTION MEDICINES

COM
76155X100
$224.05M
8 %

2,812,928

---

PHARVARIS

COM
N69605108
$222.87M
8 %

8,031,252

C
CNTA

CENTESSA PHARMACEUTICALS

ADS
152309100
$153M
5 %

6,117,715

N
NRIX

NURIX THERAPEUTICS

COM
67080M103
$92.9M
3 %

4,897,159

E
EWCZ

EUROPEAN WAX CENTER

CL A
29882P106
$47.2M
2 %

13,110,492

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 13